1. Hirano K, Miyauchi H, Nakano Y, Kawaguchi Y, Okamura S, Nishimura Y, Onishi T, Fujimoto S, Yamada T, Amano T. Overall survival rate of patients with triglyceride deposit cardiomyovasculopathy. JACC:Advances. In press. https://doi.org/10.1016/j.jacadv.2023.100347.
2. Aikawa T, Sai E, Kudo A, Kawaguchi Y, Takamura K, Hiki M, Yokoyama T, Miyazaki T, Fujimoto S, Shimada K, Hirano K, Daida H, Minamino T. 1H-MRS to evaluate improved triglyceride accumulation in idiopathic triglyceride deposit cardiomyovasculopathy after CNT-01 (tricaprin/trisdecanoin) administration. Endocrinol Diabetes Metab Case Rep. 2023 Apr 1; 2023(2)22-0370
3. Yasuhiro Hara, Yoshihiko Ikeda, Hayato Kimura, Shinsaku Shimamoto, Mao Ishikawa, Kunihisa Kobayashi, Hironori Nagasaka, Hisashi Shimoyama, Ken-ichi Hirano. A novel homozygous missense mutation in PNPLA2 in a patient manifesting primary triglyceride deposit cardiomyovasculopathy. Mol Genet Metab Rep. 2023;34:100960. doi: 10.1016/j.ymgmr.2023 .100960.
4. Hirano K, Higashi M, Nakajima K. Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy. European Heart Journal 2022; doi: 10.1093/eurheartj/ehac762.
5. 財満信宏, 平野賢一. 血管内の中性脂肪代謝異常と血管疾患との関わりを考える 中性脂肪と血管. 化学と生物 2022;60:627-629.
6. Chen Z, Nakajima K, Hirano K, Kamiya T, Yoshida S, Saito S, Kinuya S. Methods of calculating 123 I-β-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy. Ann Nucl Med 2022;36(11):986-997. doi: 10.1007/s12149-022-01787-9.
7. Miyauchi H, Ono R, Iimori T, Sawada K, Hoshi K, Hirano K, Kobayashi Y. Modified Algorithm Using Total Count for Calculating Myocardial Washout Rate in Single-Photon Emission Computerized Tomography. Ann Nucl Cardiol 2022; doi: 10.17996/anc.22-00172
8. Swamy MMM, Zubir MZM, Mutmainah, Tsuboi S, Murai Y, Monde K, Hirano K, Jin T. A near-infrared fluorescent long-chain fatty acid toward optical imaging of cardiac metabolism in living mice. Analyst 2022;147(19):4206-4212. doi: 10.1039/d2an00999d.
9. Miyauchi H, Hirano K, Nakano Y, Shimada K, Nishikawa M, Yamamoto H, Nakamura A, Miyake A, Aoshima C, Fujimoto S, Nakatani D, Yamada T, Amano T, Nakajima K. 123I-BMIPP scintigraphy shows that CNT-01(tricaprin) improves myocardial lipolysis in patients with idiopathic triglyceride deposit cardiomyovasculopathy: First randomized controlled, exploratory trial for TGCV. Ann Nucl Cardiol 2022; 8(1):67-75. doi:10.17996/anc.22-00167